Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
25.48
Dollar change
+2.19
Percentage change
9.39
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsEurope Return% 1Y-49.29% Total Holdings2 Perf Week-19.24%
SponsorPrecidian ETF Type Tagssingle-asset Return% 3Y- AUM3.72M Perf Month-16.54%
Fund Family Bond Type TagsNVO Return% 5Y- NAV/sh Perf Quarter-5.76%
Index- Average Maturity Tagshedge-currency Return% 10Y 52W High54.13 -52.93% Perf Half Y-4.00%
Index Weighting Commodity Type Tags- Return% SI 52W Low23.29 9.39% Perf YTD-7.13%
Active/Passive Quant Type Tags- Flows% 1M73.48% Volatility7.75% 4.20% Perf Year-49.56%
Dividend TTM0.65 (2.57%) ESG Type Tags- Flows% 3M179.59% ATR (14)1.55 Perf 3Y-
Dividend Ex-DateDec 16, 2025 Dividend Type Sector/Theme Flows% YTD73.48% RSI (14)36.77 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.90 Perf 10Y-
Expense0.19% Growth/Value SMA20-17.67% Flows% 3Y Rel Volume0.72 Prev Close23.29
Inverse/Leveraged Market Cap SMA50-11.40% Flows% 5Y Avg Volume6.28K Price25.48
IPOJan 07, 2025 Option/ShortNo / Yes SMA200-20.08% Trades Volume4,546 Change9.39%
Novo Nordisk A/S (B Shares) ADRhedged seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of Novo Nordisk A/S (B Shares) in its local market. The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of the Novo Nordisk A/S (B Shares) (the "Company"). The series will not invest directly in the company. The fund is non-diversified.